Indeks kemarin menguat dan membentuk engulfing bullish. Namun karena pola masih konsolidasi, maka penentuan trend naik adalah jika mampu tembus 7200.
Untuk hari ini Analis Teknikal menyukai saham-saham BMRI, BBNI, BUMI MDKA dan HEAL dengan rating trading buy. Namun BBRI dengan rating trading sell.
Day Trading Picks
Top Picks Today (Technical):
BMRI (6925); BUY-TP @7050-7150; Cutloss <6825
BBNI (5225); BUY-TP @5425-5475; Cutloss <5100
BUMI (100); Spec. BUY-TP @103-106; Cutloss <97
MDKA (2580); BUY-TP @2650-2740; Cutloss <2500
HEAL (1285); BUY-TP @1360-1425; Cutloss <1220
BBRI (4770); SELL-TP @4550-4450; Cover >4840
<DISC. ON>
Laporan lengkap dapat di -click di
Daily Technical SSI 2024-04-30
Samuel Sekuritas Indonesia is a leading Indonesian securities brokerage firm. Established in 1997, the firm has grown to become one of the most respected and trusted financial services companies in the country. With a wide range of services and products, Samuel Sekuritas Indonesia has become a trusted partner to many investors, both institutional and individual.
The company offers a variety of financial services, including equity, debt and derivative securities brokerage services, research and portfolio management, asset management and capital market services, as well as a range of other investment solutions. Samuel Sekuritas Indonesia is also a leader in providing financial education and training, and has established itself as a leading provider of investor relations services.
The company has a strong research capability and is committed to providing its clients with up-to-date and reliable market analysis and recommendations. It also has a team of experienced and knowledgeable professionals who are dedicated to providing quality service to its clients. As a result, Samuel Sekuritas Indonesia has become a preferred partner for many investors in Indonesia.
In addition to its financial services, Samuel Sekuritas Indonesia also offers a range of other services, such as corporate finance and advisory services, mergers and acquisitions, and venture capital.